Skip to main content
Gulf Pharmaceutical Industries logo

Gulf Pharmaceutical Industries — Investor Relations & Filings

Ticker · JULPHAR ISIN · AEG000201018 Abu Dhabi Securities Exchange Manufacturing
Filings indexed 360 across all filing types
Latest filing 2019-10-05 Board/Management Inform…
Country AE United Arab Emirates
Listing Abu Dhabi Securities Exchange JULPHAR

About Gulf Pharmaceutical Industries

https://www.Julphar.net

Gulf Pharmaceutical Industries (Julphar) is a prominent pharmaceutical manufacturer and distributor. The company specializes in producing a diverse portfolio of medicines, vaccines, and consumer healthcare products, addressing a broad spectrum of health conditions. Julphar is recognized as one of the largest generic pharmaceutical manufacturers in the Middle East and North Africa, and a leading global producer of insulin. Utilizing internationally accredited, state-of-the-art facilities, it manufactures over one million medicine boxes daily, distributing products to more than 40 countries. The company's operations emphasize high quality and safety standards in its comprehensive manufacturing capabilities.

Recent filings

Filing Released Lang Actions
خبر صحفي شركة الخليج للصناعات الدوائية
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a new Chief Financial and Strategy Officer at a pharmaceutical company. It contains no financial data, no report references, no voting results, no legal proceedings, and no regulatory certifications. It is an announcement related to senior management changes, specifically the appointment of a key executive. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is clearly an announcement, not a report or transcript.
2019-10-05 Arabic
Gulf Pharmaceutical Industries Press Release
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new Chief Finance & Strategy Officer at Julphar. It focuses on management changes and does not contain financial data, regulatory filings, or report announcements. The content clearly fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2019-10-05 English
JULPHAR Resumption
Regulatory Filings
2019-09-30 Arabic
JULPHAR Resumption
Regulatory Filings
2019-09-30 English
شركة الخليج للصناعات الدوائية نتائج اجتماع مجلس الإدارة 29/09/2019 الساعة 10:00
Regulatory Filings
2019-09-28 Arabic
Gulf Pharmaceutical Industries Board Meeting Results held on 29/09/2019 at 10:00
Regulatory Filings
2019-09-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.